✨ Medicines Distribution Consents




Health

Medicines Act 1981

Provisional Consent to the Distribution of New Medicines

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Myambutol
Active Ingredient: Ethambutol hydrochloride 100mg
Dosage Form: Tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Custom Pharmaceuticals Limited (UK), Sussex, United Kingdom
Note: This consent is valid for two years from the date of publication of this notice.

Product: Myambutol
Active Ingredient: Ethambutol hydrochloride 400mg
Dosage Form: Tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Cadila Pharmaceuticals Ltd, Gujarat State, India
Note: This consent is valid for two years from the date of publication of this notice.

Dated this 18th day of September 2014.

STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

go5932

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Tazocin EF
Active Ingredients: Piperacillin monohydrate 2g
Tazobactam 250mg
Dosage Form: Powder for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Wyeth Lederle SrL, Catania, Italy

Product: Tazocin EF
Active Ingredients: Piperacillin monohydrate 4g
Tazobactam 500mg
Dosage Form: Powder for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Wyeth Lederle SrL, Catania, Italy
Pfizer Biotech Corporation, Hsinfeng Hsiang Hsinchu Hsien, Taiwan

Dated this 19th day of September 2014.

STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

go5931

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: APO-Osteo Paracetamol 665 mg
Active Ingredient: Paracetamol 665mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Rubicon Research Pvt. Limited, Mumbai, India



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2014, No 114





✨ LLM interpretation of page content

πŸ₯ Provisional Consent to Distribution of New Medicines

πŸ₯ Health & Social Welfare
18 September 2014
Medicines Act 1981, Provisional Consent, Myambutol, Ethambutol hydrochloride
  • STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health

πŸ₯ Consent to Distribution of New Medicines

πŸ₯ Health & Social Welfare
19 September 2014
Medicines Act 1981, Consent, Tazocin EF, Piperacillin monohydrate, Tazobactam
  • STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health

πŸ₯ Consent to Distribution of New Medicines

πŸ₯ Health & Social Welfare
19 September 2014
Medicines Act 1981, Consent, APO-Osteo Paracetamol, Paracetamol
  • STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health